Fentanyl Trafficking Statistics in US 2026 | Seizures, Routes & Key Stats

Fentanyl Trafficking in America 2026

Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and approximately 100 times more potent than morphine, making it the most dangerous and lethally efficient drug ever to reach mass circulation in the United States. A therapeutically prescribed medication for severe pain and surgical anesthesia, fentanyl became the defining substance of the American drug crisis when illicitly manufactured fentanyl (IMF) — produced overwhelmingly in China and Mexico — flooded the US market beginning around 2013, replacing heroin as the primary driver of opioid overdose deaths within just three years. The drug is so potent that 2 milligrams — roughly the size of a few grains of sand — can cause a fatal overdose. It can be manufactured into counterfeit pills that are visually indistinguishable from legitimate prescription drugs like oxycodone and Xanax, mixed invisibly into heroin, cocaine, methamphetamine, and MDMA without the user’s knowledge, or pressed into any shape using industrial pill presses that traffickers now operate domestically. The US Drug Enforcement Administration (DEA) identifies fentanyl and its analogues as the #1 threat to American public safety, a classification that has remained unchanged since 2016. In October 2025, the DEA launched Fentanyl Free America — a formal initiative combining enforcement operations, public awareness, and strategic partnerships — with its first major enforcement phase operating from October 2025 through early 2026.

In 2026, the fentanyl crisis is showing its first sustained statistical signs of improvement in deaths and border seizures — while simultaneously evolving in ways that make the threat more geographically dispersed and chemically complex than at any previous point. The CDC’s most recent provisional data, released March 11, 2026 by the National Vital Statistics System, predicts 71,542 drug overdose deaths for the 12 months ending in October 2025 — a 17.1% decline from the prior year and a continuation of the dramatic downward trend that saw 2024 record an estimated 79,384–80,391 total overdose deaths, down 26.9% from the peak of 110,037 in 2023. Fentanyl remains involved in the overwhelming majority of those deaths. At the border, fentanyl trafficking at the southern border is down 56% since President Trump took office compared to the same period in 2024, according to official DHS data. Yet the DEA seized more than 4.7 million fentanyl pills and nearly 2,396 pounds of fentanyl powder in just a 30-day window from January 12 to February 10, 2026 — enough to represent 57 million deadly doses removed from communities in a single month. The gap between declining deaths, declining border seizures, and still-massive interior enforcement captures where the fentanyl crisis stands in 2026: measurably improving, not yet resolved, and actively evolving.

Interesting Fentanyl Trafficking Facts in the US 2026

Source: DEA Press Release “DEA Delivers Major Blows to Drug Cartels, Advancing a Fentanyl Free America in 2026” (March 19, 2026 — dea.gov), CBP Drug Seizure Statistics (cbp.gov — live data), DHS News “CBP Reports Drug Seizures Surge Again in August” (September 30, 2025), USAFacts “How Much Fentanyl Is Seized at US Borders Each Month” (updated with January 2026 data), CDC NCHS Overdose Prevention Data Resources (March 11, 2026 release)

The two most important numbers in this entire table sit in direct tension with each other. Border fentanyl seizures are down 56% since January 20, 2025 — a historic reduction in interdiction at the southwest border that the Trump administration attributes to its aggressive combination of military deployment, Title 8 enforcement, and diplomatic pressure on Mexico. At the same time, the DEA seized 57 million deadly doses in a single 30-day interior operation in early 2026 — enough fentanyl to kill every resident of California. Both statistics are simultaneously true. They reflect the fundamental challenge of the fentanyl crisis in 2026: the pipeline into the United States has been measurably narrowed at the border, but the existing supply already in the country, the domestic pill-pressing infrastructure that traffickers have developed, and the ongoing evolution of the drug supply ensure that interior enforcement remains a massive and ongoing undertaking regardless of what happens at the border.

The 23-fold increase in fentanyl deaths from 3,105 in 2013 to 72,776 in 2023 — documented by NIDA from CDC WONDER data — is one of the most dramatic public health trajectories in modern American history. For context: the entire US death toll from the Vietnam War was approximately 58,000. The US was losing more than that number annually to fentanyl overdoses every year from 2019 through 2024. The 2024 decline to 79,384 total overdose deaths (down 26.9%) and the CDC’s March 11, 2026 projection of 71,542 deaths for the 12-month window ending October 2025 (down 17.1%) represent the most significant sustained progress against the opioid epidemic in its history — but the January 2025 data showing a slight uptick of approximately 1,400 more deaths compared to January 2024, reported by NPR in June 2025, raises the question of whether the progress will hold or whether the decline was, as Stanford’s Keith Humphreys warned, “a one-off event rather than a fundamental change in epidemic dynamics.”

Fentanyl Overdose Death Statistics in the US 2026

Source: CDC NCHS Data Resources page (updated March 11, 2026 — NVSS provisional data release), NCHS Data Brief No. 549 “Drug Overdose Deaths in the United States, 2023–2024” (2025), NCHS Data Brief No. 522 (December 2024), CDC NCHS Press Release (May 2025), NIDA Drug Overdose Deaths Facts and Figures (updated June 2025, citing CDC WONDER), USAFacts “Are Fentanyl Overdose Deaths Rising in the US” (October 24, 2025), NPR “New Report: US Drug Overdose Deaths Rise After Hopeful Decline” (June 18, 2025)

The overdose death data released by the CDC’s National Center for Health Statistics on March 11, 2026 — the most recent federal government data available on the day this article is written — projects 71,542 deaths for the 12-month period ending October 2025. This continues a trajectory that has produced the most dramatic sustained decline in overdose mortality in modern US public health history: from the 114,664-death peak in the 12-month window ending August 2023, the death toll has fallen by more than 43,000 deaths per year in just over two years. The 2024 full-year figure of 79,384 deaths — a 26.9% decline from 2023 — was described by CDC director Allison Arwady as “unprecedented” to see drug deaths drop by more than 27,000 in a single year, saving more than 70 lives every day. Driving this decline has been the synthetic opioid (primarily fentanyl) death rate, which showed the largest single-year decline of any drug type from 2023 to 2024 — a reduction in opioid-involved deaths from an estimated 83,140 in 2023 to 54,743 in 2024.

The geographic disparity in fentanyl deaths — ranging from 69.2 deaths per 100,000 in West Virginia to 3.3 in Nebraska in 2023 — reflects the uneven penetration of illicit fentanyl across US drug markets. West Virginia’s extreme vulnerability reflects a combination of the state’s long history with prescription opioid addiction, its geographic position along trafficking routes from the east coast, its economic conditions, and relatively limited treatment infrastructure relative to need. The states that achieved the most dramatic 2024 declines — including Ohio, West Virginia, Virginia, Michigan, Wisconsin, Louisiana, and New Hampshire — include some of the same states that suffered the worst per-capita impact during the peak years, suggesting that in the most severely affected communities, the factors driving the nationwide decline are operating most powerfully. Those factors, per multiple addiction researchers cited in the NPR report of June 2025, include the end of COVID-era disruptions that had fragmented treatment services, increased naloxone availability, possible weakening in street fentanyl potency in some markets, and expanded access to medications for opioid use disorder.

Fentanyl Border Seizure Statistics in the US 2026

Source: USAFacts “How Much Fentanyl Is Seized at US Borders Each Month” (updated with January 2026 CBP data — usafacts.org), DHS News “CBP Reports Drug Seizures Surge Again in August” (September 30, 2025 — dhs.gov), CBP Frontline Against Fentanyl page (cbp.gov — official CBP operations tracker), The World Data Drug Seizure Statistics in US 2025 (November 25, 2025)

The 56% decline in fentanyl trafficking at the southern border since January 20, 2025 — documented in the official DHS press release of September 30, 2025 — is the most significant reduction in southern border fentanyl flow in the program’s recorded history and represents the central enforcement achievement that the Trump administration cites in its border security narrative. The data source is CBP’s own operational statistics, published by DHS. The mechanism is the combination of military troop deployments to the border, elimination of the CBP One scheduling app that had allowed migrants to schedule legal entry, reinstated Remain in Mexico protocols, and aggressive intelligence-sharing and law enforcement cooperation with Mexican authorities under diplomatic pressure. The USAFacts analysis of monthly CBP data confirms the trajectory: January 2026 border seizures of 785 pounds represent a 24% reduction from the same cumulative point in 2025, showing the trend is sustained into 2026.

The critical caveat in the border seizure data — stated explicitly by both USAFacts and DHS in the same documents that report the seizure numbers — is the interception rate problem. A 2021 DHS study found that CBP intercepted only approximately 3% of cocaine trafficked through official ports of entry. No equivalent interception rate study has been published specifically for fentanyl. USAFacts notes that ~80% of people attempting unauthorized border crossings are intercepted, but fentanyl primarily moves through official ports of entry in vehicles driven by US citizens — suggesting the interception rate for the dominant smuggling method may be closer to the 3% cocaine figure than the 80% unauthorized crossing figure. In other words: if border seizures are declining, it could reflect genuine reduced trafficking volume, or it could reflect reduced CBP detection efficiency. Official government sources acknowledge this limitation directly, and it is fundamental to interpreting the 56% decline figure accurately.

DEA Fentanyl Seizure Statistics in 2026

Source: DEA Official Press Release “DEA Delivers Major Blows to Drug Cartels, Advancing a Fentanyl Free America in 2026” (March 19, 2026 — dea.gov), DEA Rocky Mountain Field Division 2025 Seizure Statistics (January 14, 2026 — dea.gov), DEA South Dakota 2025 Fentanyl Seizures (January 22, 2026 — dea.gov), The World Data Drug Seizure Statistics in US 2025 (November 25, 2025)

The DEA’s March 19, 2026 press release — published just 8 days before the writing of this article — is the most current and primary-sourced federal law enforcement document on fentanyl seizures available. Its headline figure of 57 million deadly doses removed from communities in 30 days — representing just one of the DEA’s operational windows, not its full-year activity — illustrates the scale at which fentanyl trafficking continues to operate in the United States interior regardless of the border dynamics. The concurrent seizure of 147,797 pounds of cocaine, 21,000 pounds of methamphetamine, and more than 26 million methamphetamine pills in the same 30-day operation reflects the consolidation of cartel distribution infrastructure: the same transnational criminal organizations (TCOs) that move fentanyl move all other drug categories through the same distribution networks, making major fentanyl operations simultaneously effective against the broader drug supply.

The Rocky Mountain Field Division’s record-shattering 2025 performance — 8.73 million fentanyl pills seized across Colorado, Utah, Wyoming, and Montana — contextualizes the Albuquerque 2.7-million-pill single seizure within a broader regional enforcement surge. Colorado’s 76% year-over-year increase and Utah’s doubling of pill seizures in 2025 reflect the geographic diffusion of fentanyl distribution into Mountain West states that had previously seen lower trafficking volumes. DEA Special Agent in Charge David Olesky’s statement — “Colorado saw a 76% increase in pill seizures year-over-year. Utah pill seizures doubled. This should not only be a wake-up call, but a jolt to every citizen in our four-state region” — captures the operational assessment: while the nation’s border metrics improve, fentanyl’s presence in interior US markets is not contracting proportionally, because the existing supply chain infrastructure and domestic distribution networks are not dismantled by border enforcement alone.

Fentanyl Trafficking Routes & Methods Statistics in 2026

Source: USAFacts (updated with January 2026 CBP data), DEA Press Release March 19, 2026, CBP Frontline Against Fentanyl page (cbp.gov), The World Data (November 25, 2025 — citing DEA and CBP), NPR (June 18, 2025)

The 84.6% of fentanyl seized at official ports of entry in January 2026 — confirmed by CBP’s own operational data cited by USAFacts — is the route statistic with the most significant policy implications. It directly contradicts the framing that fentanyl primarily enters the United States through unauthorized border crossings. The 2023 DHS report that established the definitive baseline found that fentanyl is primarily found in vehicles driven by US citizens at official ports of entry — not carried by migrants crossing between ports. This distinction matters enormously for enforcement strategy: the dominant fentanyl entry method requires inspection technology upgrades at ports (better X-ray scanning, drug detection dogs, secondary inspection capacity), intelligence-driven interdiction, and cooperation with Mexican and Chinese governments to address precursor supply chains — not primarily more barriers or agents between ports. The Operation Artemis seizure of over 13,000 pounds of fentanyl precursor chemicals reflects the most upstream enforcement approach: targeting the chemicals that Mexican cartels use to manufacture fentanyl before they are synthesized, rather than attempting to intercept every finished pill.

The emergence of xylazine and medetomidine as adulterants in the fentanyl supply — documented by NPR’s June 2025 reporting on addiction researchers’ analysis — is the most concerning 2025–2026 development in the drug supply itself. Xylazine is a veterinary tranquilizer that, when mixed with fentanyl, produces a longer and deeper sedation that users sometimes seek for a prolonged effect but that creates severe skin lesions at injection sites and — critically — cannot be reversed by naloxone, the medication that has saved hundreds of thousands of lives from fentanyl overdoses. When a first responder administers naloxone to someone who has overdosed on fentanyl-xylazine mixtures, the naloxone reverses the fentanyl component but the xylazine keeps the person sedated and may still cause fatal respiratory depression if not managed with additional medical intervention. The 640 pounds of xylazine seized in February 2025 — categorized in CBP’s “other illicit substances” data — represents only the fraction that was intercepted at the border, not the volume already in distribution within US drug markets.

Fentanyl Seizure Statistics by Region in the US 2026

Source: DEA March 19, 2026 press release, DEA January 14, 2026 (Rocky Mountain), DEA January 22, 2026 (South Dakota), DEA January 29, 2026 (Detroit), CBP Frontline Against Fentanyl page, The World Data (November 25, 2025), DHS September 30, 2025

The regional data reveals that fentanyl trafficking is not a border problem — it is a national distribution problem that extends from Albuquerque to Baltimore to Chattanooga to New York City. The DEA’s Rocky Mountain Field Division’s 8.73 million pill seizure across Colorado, Utah, Wyoming, and Montana in 2025 — states not typically associated with the highest drug trafficking volumes — demonstrates the geographic maturation of the fentanyl distribution network. Cartels have moved from concentrating distribution in coastal gateway cities to operating sophisticated interior distribution networks that serve rural and mountain states that had previously been served primarily by prescription opioids. DEA Special Agent in Charge Olesky’s characterization of the Rocky Mountain numbers as a “wake-up call” and “a jolt to every citizen” reflects this geographic expansion as the most significant current trend in the intelligence picture.

The South Dakota data — just 4 pounds of fentanyl powder and 27,500 pills representing 146,000 estimated fatal doses — provides the clearest single illustration of fentanyl’s lethality per unit weight. South Dakota is one of the lowest-volume fentanyl states in the country, with just 42 total fentanyl deaths in 2023 (the fewest of any US state per USAFacts). Yet even at that relatively low trafficking volume, a DEA field division’s 2025 seizure was sufficient to calculate six-figure potential death prevention. The South Dakota data also provides a useful calibration for the massive numbers from other regions: the 2.7 million pill Albuquerque seizure in April 2025 — at the same average lethal dose calculation — represents in excess of 700,000 potential fatal doses. And the DEA’s 30-day national operation from January 12 to February 10, 2026, which removed 57 million deadly doses from the supply chain, represents a quantity sufficient to kill every resident of California — from just 30 days of a single coordinated enforcement operation.

Fentanyl Trafficking Impact on the US Economy in 2026

Source: DEA Press Release March 19, 2026, CDC Overdose Prevention page (updated March 11, 2026 — data from NVSS March 11, 2026 release), NPR (June 18, 2025)

Drug overdose is a leading cause of preventable death in the United States — a fact stated explicitly on the CDC’s Overdose Prevention page, updated as recently as two weeks ago. The treatment gap data on that same page — 54.2 million Americans aged 12 and older needed substance use disorder treatment in 2023, but only 12.8 million people received it — represents perhaps the most consequential public health failure underlying the entire fentanyl crisis. Supply-side enforcement, no matter how effective, operates against a demand base of tens of millions of Americans for whom addiction treatment services are either unavailable, unaffordable, or inaccessible. The largest source of insurance coverage for Americans experiencing addiction is Medicaid, per the American Society of Addiction Medicine — a dependency noted prominently by NPR in June 2025 as political debates over Medicaid funding intensified. Any reduction in Medicaid coverage for substance use disorder treatment directly reduces access to the evidence-based medications — primarily buprenorphine and methadone — that research consistently shows are the most effective interventions for opioid use disorder.

The Trump administration’s designation of multiple Mexican cartels as Foreign Terrorist Organizations (FTOs) in early 2025 — and the DEA administrator’s characterization of them as operating “like multi-billion-dollar corporations” in the March 19, 2026 press release — represents a doctrinal escalation in how the US government frames the fentanyl trafficking threat. The FTO designation enables a broader set of legal authorities for prosecution, financial sanctions, and international law enforcement cooperation than traditional drug trafficking organization designations. It also enables prosecution of individuals who provide “material support” to cartels under counterterrorism statutes rather than solely drug trafficking statutes, potentially reaching a wider network of cartel financiers, money launderers, and logistics providers. Whether this doctrinal shift translates into meaningfully greater disruption of cartel operations — given that the cartels’ core leadership and infrastructure largely operates within Mexico beyond direct US law enforcement reach — will be one of the defining questions of the 2026 enforcement picture.

Disclaimer: The data reports published on The Global Files are sourced from publicly available materials considered reliable. While efforts are made to ensure accuracy, no guarantees are provided regarding completeness or reliability. The Global Files is not liable for any errors, omissions, or damages resulting from the use of these reports.